Fresenius SE & Co KGAA O.N. (FREG)

Currency in EUR
41.040
-1.340(-3.16%)
Real-time Data·
Earnings results expected in 13 days
FREG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
40.77042.300
52 wk Range
39.19052.960
Key Statistics
Prev. Close
42.38
Open
42.265
Day's Range
40.77-42.3
52 wk Range
39.19-52.96
Volume
406.4K
Average Volume (3m)
946.04K
1-Year Change
7.0796%
Book Value / Share
33.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FREG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.686
Upside
+35.69%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Employees
155186
Market
Germany

Compare FREG to Peers and Sector

Metrics to compare
FREG
Peers
Sector
Relationship
P/E Ratio
15.8x16.9x−0.5x
PEG Ratio
0.090.300.00
Price/Book
1.3x1.7x2.6x
Price / LTM Sales
1.1x1.7x3.2x
Upside (Analyst Target)
32.0%68.1%45.2%
Fair Value Upside
Unlock31.0%6.4%Unlock

Analyst Ratings

12 Buy
2 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 55.686
(+35.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.73%
Dividend Yield
2.43%
Industry Median 2.95%
Annualised payout
1.05
Paid annually
5-Years Growth
+3.60%
Growth Streak

Earnings

Latest Release
24/02/2026
EPS / Forecast
0.78 / 0.91
Revenue / Forecast
5.88B / 5.86B
EPS Revisions
Last 90 days

People Also Watch

552.70
MUVGn
-1.09%
265.000
DB1Gn
-0.11%
57.250
EVDG
+0.35%
39.445
FMEG
+0.62%

FAQ

What Is the Fresenius SE (Xetra: FREG) Share Price Today?

The Fresenius SE stock price today is 41.040 EUR.

What Stock Exchange Does Fresenius SE (FREG) Trade On?

Fresenius SE is listed and trades on the Frankfurt Stock Exchange.

What Is the Ticker (Stock Symbol) for Fresenius SE?

The stock symbol (also called a 'ticker') for Fresenius SE is "FREG."

Does Fresenius SE Pay Dividends? What’s The Current FREG Dividend Yield?

Yes, FREG Pays Dividends to its Shareholders. The current Fresenius SE dividend yield is 2.43%.

What Is the Current Fresenius SE Market Capitalisation?

As of today, Fresenius SE (Xetra: FREG) market cap is 23.230B EUR.

What Is Fresenius SE's (FREG) Earnings Per Share (TTM)?

The Fresenius SE EPS is currently 2.727 (Trailing Twelve Months).

When Is the Next Fresenius SE Earnings Date?

Fresenius SE's next earnings report will be released on 06/05/2026.

Is FREG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Fresenius SE moving averages and other technical indicators, the daily buy/sell signal for FREG stock is Strong Sell.

How Many Times Has Fresenius SE Stock Split?

Fresenius SE has split 4 times. (See the FREG stock split history page for full effective split date and price information.)

How Many Employees Does Fresenius SE Have?

Fresenius SE has 155186 employees, based on their latest Companies House report.

What is the current trading status of Fresenius SE (Xetra: FREG)?

As of 23/04/2026, Fresenius SE (FREG) is trading at a share price of 41.040 EUR, with a previous close of 42.380 EUR. The stock has fluctuated within a day range of 40.770 EUR to 42.300 EUR, while its 52-week range spans from 39.190 EUR to 52.960 EUR.

What Is Fresenius SE (FREG) Price Target According to Analysts?

The average 12-month price target for Fresenius SE is 55.686 EUR, with a high estimate of 58 EUR and a low estimate of 50 EUR. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +35.69% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.